FindTrial
Sign In

comparing duration of phototherpy in neonatal jaundice between two different guidelines

A Randomised controlled trial comparing the duration of phototherapy following NICE(UK) and AAP guidelines in neonatal hyperbilirubinemia.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/02/011940
Enrollment
128
Registered
2018-02-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- icteric newborn

Interventions

Intervention1: intervention one arm comprising of 64 babies who will be chosen randomly for phototherapy by AAP guideline will receive photoyherapy according to the hour specific nomogram.serum biliru

Sponsors

IPGMER Kolkata
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All babies requiring phototherapy for neonatal hyperbilirubinemia between 35-42 weeks of gestational age will be included in the study.

Exclusion criteria

Exclusion criteria: a.Any baby having major congenital malformation b.Babies with haemolytic jaundice

Design outcomes

Primary

MeasureTime frame
The primary outcome variable is duration of phototherapy.Timepoint: 6hrs,12hrs,24hrs,48hrs.—

Secondary

MeasureTime frame
The secondary outcome variables are treatment failure and rebound hyperbilirubinemia.Timepoint: 6hrs,12 hrs,24 hrs,48 hrs—

Countries

India

Contacts

Public ContactDr Ratan Kumar Biwas

The Institute of Post Graduate Medical Education Research IPGMER

dr.dineshmunian@gmail.com9163288916

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026